INDEMNIFICATION AGREEMENTIndemnification Agreement • May 2nd, 2018 • Abpro Corp • Pharmaceutical preparations • Delaware
Contract Type FiledMay 2nd, 2018 Company Industry JurisdictionTHIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , 2018, between Abpro Corporation, a Delaware corporation (the “Company”), and (“Indemnitee”).
ABPRO CORPORATION [●] Shares Common Stock ($[●] par value per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • May 2nd, 2018 • Abpro Corp • Pharmaceutical preparations • New York
Contract Type FiledMay 2nd, 2018 Company Industry Jurisdiction
Confidential EXCLUSIVE LICENSE AGREEMENT for MSK’s technology “Her2-huOKT3 bispecific Antibody—SK2014-064” No binding agreement between the Parties will exist until this Agreement has been signed by both Parties. Unsigned drafts of this Agreement...Exclusive License Agreement • May 2nd, 2018 • Abpro Corp • Pharmaceutical preparations • New York
Contract Type FiledMay 2nd, 2018 Company Industry JurisdictionThis Exclusive License Agreement (the “Agreement”) is effective on the date of the last signature below (“Effective Date”), and is by and between Memorial Sloan Kettering Cancer Center (hereinafter referred to as “MSK”), a New York not-for-profit corporation with principal offices at 1275 York Avenue, New York NY 10065, and AbPro Corporation, a Delaware corporation with principal offices located at 65 Cummings Park Drive, Woburn, Massachusetts 01801 (“LICENSEE”). MSK and LICENSEE are sometimes referred to singly as “Party” and collectively as “Parties”.
LICENSE AGREEMENTLicense Agreement • May 2nd, 2018 • Abpro Corp • Pharmaceutical preparations • Delaware
Contract Type FiledMay 2nd, 2018 Company Industry JurisdictionTHIS COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is entered into as of this 26th day of August, 2016 (the “Effective Date”), by and between MedImmune Limited, a company incorporated in England and Wales (under company number 2451177) whose registered office is Milstein Building, Granta Park, Cambridge, CB21 UK (“Licensor”), AbMed Corporation a Delaware corporation with its principal place of business at 160 Greentree Drive, Suite 101, Dover, Kent County, Delaware 19904 (“Company”) and, solely with respect to the specified provisions hereof, AbPro Corporation, a Delaware corporation with its principal place of business at 65 Cummings Park Drive, Woburn, Massachusetts 01801 (“AbPro”). Licensor, Company and AbPro are sometimes collectively referred to herein as the “Parties” and each separately as a “Party.”